BrightInsight Announces Appointment of Digital Biotech Veteran Meinhard F. Schmidt to Advisory Council
Schmidt Brings 25 Years of Executive Experience in Healthcare, Life Sciences, Diagnostics and Medical Devices…
Schmidt Brings 25 Years of Executive Experience in Healthcare, Life Sciences, Diagnostics and Medical Devices…
Press Release Nicox Provides Third Quarter 2021 Business and Financial Highlights VYZULTA® and ZERVIATE® prescriptions…
Invisible Nation is a worldwide network of patient organizations committed to driving a decline in…
Maxigesic® IV provides a non-opioid, dual mode-of-action pain management alternative to traditional analgesics Liège, Belgium…
–Presentation of Phase 3 clinical data on linzagolix for the treatment of uterine fibroids and…
Amendment to ongoing collaboration allows Wave to advance or partner CNS programs, including those using…
HOLLISTON, Mass., Oct. 18, 2021 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce…
ROCKVILLE, Md., Oct. 18, 2021 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen” or the…
— TORC 1/2 inhibitor sapanisertib and SYK inhibitor mivavotinib strengthen Company’s precision oncology pipeline —…
UNIONDALE, N.Y., Oct. 18, 2021 (GLOBE NEWSWIRE) — Angion Biomedica Corp (NASDAQ:ANGN), a late-stage biopharmaceutical…
— Potential $1 Billion Addressable Market Opportunity in the United States BOSTON, Oct. 18, 2021…
SUL-DUR first to achieve statistical non-inferiority in 28-day all-cause mortality in carbapenem-resistant Acinetobacter (CRAB) patients…
FOSTER CITY, Calif., Oct. 18, 2021 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the…
Oral Presentation of Clinical Data for TIL in Combination with Pembrolizumabin Immune-Checkpoint Inhibitor Naïve Patients…
Co-founded by Crinetics, 5AM Ventures and Frazier Healthcare Partners, the New Company Launches with $30M…
Four poster presentations add to the evidence of the beneficial effects of lanifibranor therapy on…
Sandusky, OH, Oct. 18, 2021 (GLOBE NEWSWIRE) — PAO Group, Inc. (OTC Pink: PAOG) earlier…
PRESS RELEASE AB SCIENCE GRANTED AUTHORIZATION FROM THE FRENCH HEALTH AUTHORITY (ANSM) TO INITIATE…
KEY FIGURES RevenueYear-to-date September 30, 2021 €817.7 million At constant exchange rates and scope1 +21.2%…
CAMBRIDGE, Mass., Oct. 18, 2021 (GLOBE NEWSWIRE) — Alphageneron Pharmaceuticals, Inc. (“Alphageneron” or the “Company”),…